|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Manufacturing fees | |||||
| Licensing fees | |||||
| Manufacturing | |||||
| Licensing | |||||
| Total revenue | |||||
| Cost of manufacturing | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Non-cash compensation through issuance of stock options | |||||
| Impairment of intangible assets | |||||
| Depreciation and amortization | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other income (expense): | |||||
| Change in fair value of derivative financial instruments - warrants | |||||
| Change in fair value of stock-based liabilities | |||||
| Gain from settlement agreements | |||||
| Interest expense and amortization of debt issuance costs | |||||
| Interest income | |||||
| Other income | |||||
| Other income (expense), net | |||||
| Income (loss) before income taxes | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Basic net income (loss) per share | |||||
| Diluted net income (loss) per share | |||||
| Basic weighted average common stock outstanding | |||||
| Diluted weighted average common stock outstanding | |||||
Loading...